Fortrea Announces Date for First Quarter 2025 Financial Results and Conference Call
Rhea-AI Summary
Fortrea (FTRE), a leading global contract research organization (CRO), has scheduled its first quarter 2025 financial results announcement for Monday, May 12, 2025, before market opening. The company will host a conference call at 9:00 am ET the same day, featuring a financial results review and Q&A session.
Participants interested in joining the earnings call must register through the Fortrea Investor Relations website and are advised to connect 10 minutes before the call starts. A replay will be available in the events and presentations section of the company's IR website after the event.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, FTRE declined 9.33%, reflecting a notable negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
DURHAM, N.C., April 15, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that it will release its first quarter 2025 financial results before the market opens on Monday, May 12, 2025. Fortrea will host a conference call at 9:00 am ET that day to review its financial results and conduct a question-and-answer session.
To participate in the earnings call, participants should register online at the Fortrea Investor Relations website. To avoid potential delays, please join at least 10 minutes prior to the start of the call. The conference call can also be accessed through the following earnings webcast link.
A replay of the live conference call will be available shortly after the conclusion of the event and accessible on the events and presentations section of the Fortrea Investor Relations website.
About Fortrea
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, biotechnology, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients. Fortrea provides phase I-IV clinical trial management, clinical pharmacology and consulting services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team working in about 100 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com and follow us on LinkedIn and X (formerly Twitter).
Fortrea Contacts
Hima Inguva (Investors) – 877-495-0816, hima.inguva@fortrea.com
Sue Zaranek (Media) – 919-943-5422, media@fortrea.com
Kate Dillon (Media) – 646-818-9115, kdillon@prosek.com
FAQ
When will Fortrea (FTRE) release its Q1 2025 earnings?
What time is Fortrea's Q1 2025 earnings conference call?
How can investors join Fortrea's Q1 2025 earnings call?
Will there be a replay available for Fortrea's Q1 2025 earnings call?
